LP
ETON icon

LMR Partners’s Eton Pharmaceutcials ETON Stock Holding History

LMR Partners’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-13,574
Closed -$176K – 1463
2025
Q1 		$176K Buy
+13,574
New +$205K ﹤0.01% 1080

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return

LMR Partners's ETON Position: Q2 2025 in Review

LMR Partners sold out of Eton Pharmaceutcials (ETON) in Q2 2025, closing a stake of 13,574 shares — an estimated $176K sold.

LMR Partners first reported a position in ETON in Q1 2025 and held it in 1 quarter. The position peaked at $176K in Q1 2025. 87 funds tracked by Wall St. Rank hold ETON as of Q2 2025.

  • LMR Partners reported no remaining Eton Pharmaceutcials position as of Q2 2025 after selling out during the quarter.
  • LMR Partners sold 13,574 Eton Pharmaceutcials shares in Q2 2025, an estimated $176K.
  • LMR Partners first reported a position in Eton Pharmaceutcials in Q1 2025 and held it in 1 quarter.
  • LMR Partners's Eton Pharmaceutcials position peaked at $176K in Q1 2025.
  • 87 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q2 2025.

Based on LMR Partners's 13F filing for Q2 2025, filed 14 Aug 2025.